Section Arrow
RLAY.NASDAQ
- Relay Therapeutics
Quotes are at least 15-min delayed:2024/06/24 08:23 EDT
Last
 6.94
+0.09 (+1.31%)
Day High 
7.09 
Prev. Close
6.85 
1-M High
8.1 
Volume 
4.00M 
Bid
6.76
Ask
7.15
Day Low
6.78 
Open
6.8 
1-M Low
6.14 
Market Cap 
909.28M 
Currency USD 
P/E -- 
%Yield
10-SMA 7.39 
20-SMA 7.1 
50-SMA 6.79 
52-W High 13.32 
52-W Low 5.7 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.63/-2.99
Enterprise Value
957.78M
Balance Sheet
Book Value Per Share
5.62
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
25.55M
Operating Revenue Per Share
0.19
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MBIOMustang Bio0.5594-0.0011-0.20%-- 
DNAGinkgo Bioworks Holdings0.4244+0.0157+3.84%-- 
KTRAKintara Therapeutics0.2472-0.0277-10.08%-- 
BMRNBioMarin Pharmaceutical83.72-0.99-1.17%79.92PE
QLGNQualigen Therapeutics0.222+0.0449+25.35%-- 
Quotes are at least 15-min delayed:2024/06/24 08:23 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.